glp 1 liver fibrosis Effects of GLP-1 receptor agonists on the degree of and CRP in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: A systematic review and meta-analysis Potential effects of GLP-1 and

Harrop, S

Brazilian evidence-based guidelines for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: a joint position statement from the Brazilian Society of En-docrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of obesity and metabolic syndrome (Abeso)

95% CI: 0.75-1.01), it did not reach statistical significance

Butler JV, Whittington JE, Holland AJ, Boer H, Clarke D, Webb T : Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study

Instead, the two groups recommend careful weighing of risks and benefits and discussion between the patient and their care team to make an informed decision

youre looking for a roadmap